| 0 |
CYSTATIN C INCREASED |
4 |
0.0312 |
| 1 |
CATHETER SITE EROSION |
2 |
0.0220 |
| 2 |
PELVIC MISALIGNMENT |
1 |
0.0196 |
| 3 |
CATHETER SITE OEDEMA |
2 |
0.0183 |
| 4 |
CATHETER SITE DISCOLOURATION |
2 |
0.0164 |
| 5 |
SCOLIOSIS SURGERY |
1 |
0.0139 |
| 6 |
MUSCLE FIBROSIS |
1 |
0.0137 |
| 7 |
VIRAL MYOSITIS |
1 |
0.0132 |
| 8 |
CATHETER SITE SCAB |
1 |
0.0093 |
| 9 |
POOR VENOUS ACCESS |
72 |
0.0070 |
| 10 |
CATHETER SITE WARMTH |
1 |
0.0061 |
| 11 |
URINARY RETENTION POSTOPERATIVE |
1 |
0.0061 |
| 12 |
EXPOSURE TO SARS-COV-2 |
10 |
0.0059 |
| 13 |
CATHETER SITE CELLULITIS |
1 |
0.0034 |
| 14 |
CATHETER SITE BRUISE |
1 |
0.0030 |
| 15 |
GASTROSTOMY |
4 |
0.0026 |
| 16 |
ASYMPTOMATIC COVID-19 |
1 |
0.0025 |
| 17 |
VIRAL RASH |
1 |
0.0025 |
| 18 |
CATHETER SITE PAIN |
5 |
0.0019 |
| 19 |
WRONG DEVICE USED |
1 |
0.0015 |
| 20 |
PROCEDURAL ANXIETY |
1 |
0.0015 |
| 21 |
GRAVITATIONAL OEDEMA |
1 |
0.0014 |
| 22 |
INTENTIONAL DOSE OMISSION |
38 |
0.0013 |
| 23 |
CREATINE KINASE INCREASED |
1 |
0.0013 |
| 24 |
HAND-FOOT-AND-MOUTH DISEASE |
1 |
0.0012 |
| 25 |
CULTURE POSITIVE |
1 |
0.0012 |
| 26 |
SKIN WOUND |
2 |
0.0012 |
| 27 |
INFUSION SITE DISCOLOURATION |
1 |
0.0011 |
| 28 |
PRODUCT APPEARANCE CONFUSION |
1 |
0.0011 |
| 29 |
CENTRAL VENOUS CATHETERISATION |
3 |
0.0010 |
| 30 |
PRODUCT TEMPERATURE EXCURSION ISSUE |
5 |
0.0010 |
| 31 |
CATHETER SITE ERYTHEMA |
2 |
0.0009 |
| 32 |
PRODUCT NAME CONFUSION |
1 |
0.0009 |
| 33 |
CATHETER SITE DISCHARGE |
1 |
0.0009 |
| 34 |
PHARYNGEAL INFLAMMATION |
1 |
0.0008 |
| 35 |
CATHETER SITE INFECTION |
3 |
0.0008 |
| 36 |
IMPLANTABLE DEFIBRILLATOR INSERTION |
1 |
0.0008 |
| 37 |
INTERCEPTED PRODUCT PRESCRIBING ERROR |
1 |
0.0008 |
| 38 |
NOROVIRUS INFECTION |
1 |
0.0007 |
| 39 |
SKIN STRIAE |
1 |
0.0007 |
| 40 |
INTERCEPTED PRODUCT DISPENSING ERROR |
1 |
0.0006 |
| 41 |
VEIN RUPTURE |
1 |
0.0006 |
| 42 |
DRUG MONITORING PROCEDURE NOT PERFORMED |
1 |
0.0006 |
| 43 |
DEVICE RELATED SEPSIS |
1 |
0.0005 |
| 44 |
MUSCLE CONTRACTURE |
1 |
0.0005 |
| 45 |
DEVICE DEPOSIT ISSUE |
1 |
0.0005 |
| 46 |
INFUSION SITE EXTRAVASATION |
3 |
0.0005 |
| 47 |
SLEEP DEFICIT |
1 |
0.0005 |
| 48 |
PRODUCT DOSE OMISSION ISSUE |
135 |
0.0005 |
| 49 |
PRODUCT COMMUNICATION ISSUE |
4 |
0.0005 |
| 50 |
INFECTIOUS MONONUCLEOSIS |
1 |
0.0004 |
| 51 |
PERIARTHRITIS |
1 |
0.0004 |
| 52 |
PRODUCT DISTRIBUTION ISSUE |
4 |
0.0004 |
| 53 |
NO ADVERSE EVENT |
78 |
0.0004 |
| 54 |
RESPIRATORY TRACT INFECTION VIRAL |
1 |
0.0004 |
| 55 |
PRODUCT PACKAGING CONFUSION |
1 |
0.0004 |
| 56 |
DEVICE INFUSION ISSUE |
1 |
0.0004 |
| 57 |
PROTEIN URINE PRESENT |
2 |
0.0004 |
| 58 |
URINARY TRACT INFECTION BACTERIAL |
1 |
0.0004 |
| 59 |
DEVICE ISSUE |
35 |
0.0004 |
| 60 |
PROTEIN TOTAL INCREASED |
1 |
0.0004 |
| 61 |
BLOOD POTASSIUM ABNORMAL |
1 |
0.0004 |
| 62 |
BLOOD PHOSPHORUS INCREASED |
1 |
0.0004 |
| 63 |
ANAL HAEMORRHAGE |
1 |
0.0004 |
| 64 |
DEVICE OCCLUSION |
5 |
0.0004 |
| 65 |
UPPER RESPIRATORY TRACT CONGESTION |
1 |
0.0003 |
| 66 |
PNEUMONIA BACTERIAL |
3 |
0.0003 |
| 67 |
SCOLIOSIS |
2 |
0.0003 |
| 68 |
PNEUMONIA VIRAL |
1 |
0.0003 |
| 69 |
PRODUCT PREPARATION ISSUE |
2 |
0.0003 |
| 70 |
INFUSION SITE HAEMORRHAGE |
1 |
0.0003 |
| 71 |
WOUND DEHISCENCE |
1 |
0.0003 |
| 72 |
TYPE I HYPERSENSITIVITY |
1 |
0.0003 |
| 73 |
PHARYNGITIS STREPTOCOCCAL |
3 |
0.0003 |
| 74 |
FOOD INTOLERANCE |
1 |
0.0003 |
| 75 |
CARDIAC DYSFUNCTION |
1 |
0.0003 |
| 76 |
TROPONIN INCREASED |
2 |
0.0003 |
| 77 |
CARDIOPULMONARY FAILURE |
1 |
0.0003 |
| 78 |
FUNGAL SKIN INFECTION |
1 |
0.0002 |
| 79 |
INFUSION SITE PAIN |
3 |
0.0002 |
| 80 |
TIBIA FRACTURE |
1 |
0.0002 |
| 81 |
BREATH SOUNDS ABNORMAL |
1 |
0.0002 |
| 82 |
HYPERVOLAEMIA |
1 |
0.0002 |
| 83 |
FOOT OPERATION |
1 |
0.0002 |
| 84 |
PHLEBITIS |
1 |
0.0002 |
| 85 |
FEMORAL NECK FRACTURE |
1 |
0.0002 |
| 86 |
ASPIRATION |
2 |
0.0002 |
| 87 |
FAECALOMA |
1 |
0.0002 |
| 88 |
FEELING OF BODY TEMPERATURE CHANGE |
1 |
0.0002 |
| 89 |
ADRENAL INSUFFICIENCY |
2 |
0.0002 |
| 90 |
DERMATITIS ACNEIFORM |
1 |
0.0002 |
| 91 |
INFUSION SITE SWELLING |
1 |
0.0002 |
| 92 |
ACUTE RESPIRATORY FAILURE |
3 |
0.0002 |
| 93 |
WALKING AID USER |
1 |
0.0002 |
| 94 |
ATRIOVENTRICULAR BLOCK COMPLETE |
1 |
0.0001 |
| 95 |
PRODUCT LABEL ISSUE |
1 |
0.0001 |
| 96 |
DEFAECATION URGENCY |
1 |
0.0001 |
| 97 |
FEAR OF INJECTION |
1 |
0.0001 |
| 98 |
PRODUCT SUPPLY ISSUE |
1 |
0.0001 |
| 99 |
CARDIOGENIC SHOCK |
2 |
0.0001 |
| 100 |
ACCIDENTAL UNDERDOSE |
2 |
0.0001 |
| 101 |
PRODUCT DISPENSING ERROR |
3 |
0.0001 |
| 102 |
GASTROENTERITIS |
2 |
0.0001 |
| 103 |
MAJOR DEPRESSION |
1 |
0.0001 |
| 104 |
ILLNESS |
14 |
0.0001 |
| 105 |
PEMPHIGOID |
1 |
0.0001 |
| 106 |
COVID-19 |
23 |
0.0001 |
| 107 |
DEVICE RELATED INFECTION |
2 |
0.0001 |
| 108 |
PRODUCT ADMINISTRATION INTERRUPTED |
1 |
0.0001 |
| 109 |
OBSESSIVE-COMPULSIVE DISORDER |
1 |
0.0001 |
| 110 |
BLOOD POTASSIUM INCREASED |
2 |
0.0001 |
| 111 |
DECUBITUS ULCER |
1 |
0.0001 |
| 112 |
SPINAL COMPRESSION FRACTURE |
1 |
0.0001 |
| 113 |
GAIT INABILITY |
4 |
0.0001 |
| 114 |
INFUSION SITE ERYTHEMA |
1 |
0.0001 |
| 115 |
GROIN PAIN |
1 |
0.0001 |
| 116 |
GASTROENTERITIS VIRAL |
2 |
0.0001 |
| 117 |
UPPER RESPIRATORY TRACT INFECTION |
5 |
0.0001 |
| 118 |
SPUTUM DISCOLOURED |
1 |
0.0001 |
| 119 |
PRODUCT PACKAGING ISSUE |
1 |
0.0001 |
| 120 |
LOWER LIMB FRACTURE |
2 |
0.0001 |
| 121 |
DIZZINESS POSTURAL |
1 |
0.0001 |
| 122 |
BLOOD POTASSIUM DECREASED |
3 |
0.0001 |
| 123 |
PRODUCT ADMINISTRATION ERROR |
2 |
0.0001 |
| 124 |
FEMUR FRACTURE |
3 |
0.0001 |
| 125 |
DERMATITIS |
2 |
0.0001 |
| 126 |
POOR QUALITY PRODUCT ADMINISTERED |
1 |
0.0001 |
| 127 |
SKIN LACERATION |
1 |
0.0001 |
| 128 |
PRODUCT PRESCRIBING ISSUE |
2 |
0.0001 |
| 129 |
INFLUENZA |
10 |
0.0001 |
| 130 |
MALNUTRITION |
1 |
0.0001 |
| 131 |
BLOOD CALCIUM DECREASED |
1 |
0.0001 |
| 132 |
COVID-19 PNEUMONIA |
1 |
0.0001 |
| 133 |
SPINAL OPERATION |
1 |
0.0001 |
| 134 |
GENERALISED OEDEMA |
1 |
0.0001 |
| 135 |
PNEUMONIA ASPIRATION |
2 |
0.0001 |
| 136 |
THERAPY CESSATION |
4 |
0.0001 |
| 137 |
HIATUS HERNIA |
1 |
0.0001 |
| 138 |
RESPIRATORY TRACT INFECTION |
2 |
0.0001 |
| 139 |
PULMONARY CONGESTION |
1 |
0.0001 |
| 140 |
EAR INFECTION |
2 |
0.0001 |
| 141 |
DEHYDRATION |
10 |
0.0001 |
| 142 |
DEVICE DISLOCATION |
3 |
0.0001 |
| 143 |
COMPLICATION ASSOCIATED WITH DEVICE |
1 |
0.0001 |
| 144 |
UNDERDOSE |
5 |
0.0001 |
| 145 |
CARDIOMYOPATHY |
1 |
0.0001 |
| 146 |
EPILEPSY |
2 |
0.0001 |
| 147 |
INSURANCE ISSUE |
1 |
0.0001 |
| 148 |
RESPIRATORY TRACT CONGESTION |
1 |
0.0001 |
| 149 |
CHOLELITHIASIS |
2 |
0.0001 |
| 150 |
URINARY RETENTION |
2 |
0.0001 |
| 151 |
CANDIDA INFECTION |
1 |
0.0001 |
| 152 |
MUSCULOSKELETAL DISCOMFORT |
1 |
0.0001 |
| 153 |
PARANOIA |
1 |
0.0001 |
| 154 |
PYREXIA |
20 |
0.0001 |
| 155 |
CRYING |
2 |
0.0001 |
| 156 |
OROPHARYNGEAL PAIN |
5 |
0.0001 |
| 157 |
PHOTOPHOBIA |
1 |
0.0001 |
| 158 |
BLOOD SODIUM DECREASED |
1 |
0.0001 |
| 159 |
SLEEP APNOEA SYNDROME |
1 |
0.0001 |
| 160 |
HEART RATE INCREASED |
5 |
0.0001 |
| 161 |
UPPER LIMB FRACTURE |
1 |
0.0001 |
| 162 |
MALAISE |
22 |
0.0001 |
| 163 |
PRODUCT PHYSICAL ISSUE |
1 |
0.0000 |
| 164 |
BODY TEMPERATURE INCREASED |
1 |
0.0000 |
| 165 |
TACHYCARDIA |
4 |
0.0000 |
| 166 |
GASTROINTESTINAL DISORDER |
4 |
0.0000 |
| 167 |
NEPHROLITHIASIS |
2 |
0.0000 |
| 168 |
DISEASE PROGRESSION |
5 |
0.0000 |
| 169 |
PRODUCT PRESCRIBING ERROR |
1 |
0.0000 |
| 170 |
PRODUCTIVE COUGH |
2 |
0.0000 |
| 171 |
LOCALISED INFECTION |
1 |
0.0000 |
| 172 |
OEDEMA |
2 |
0.0000 |
| 173 |
LIMB INJURY |
1 |
0.0000 |
| 174 |
PNEUMONITIS |
1 |
0.0000 |
| 175 |
CONSTIPATION |
8 |
0.0000 |
| 176 |
INFLUENZA LIKE ILLNESS |
3 |
0.0000 |
| 177 |
RESPIRATORY ARREST |
1 |
0.0000 |
| 178 |
RESPIRATORY DISTRESS |
1 |
0.0000 |
| 179 |
ANAPHYLACTIC REACTION |
2 |
0.0000 |
| 180 |
VOMITING |
17 |
0.0000 |
| 181 |
MENTAL STATUS CHANGES |
1 |
0.0000 |
| 182 |
WOUND |
1 |
0.0000 |
| 183 |
FLATULENCE |
2 |
0.0000 |
| 184 |
HYPOTENSION |
7 |
0.0000 |
| 185 |
NEEDLE ISSUE |
1 |
0.0000 |
| 186 |
NASAL CONGESTION |
2 |
0.0000 |
| 187 |
PNEUMONIA |
11 |
0.0000 |
| 188 |
LABORATORY TEST ABNORMAL |
1 |
0.0000 |
| 189 |
PSYCHOTIC DISORDER |
1 |
0.0000 |
| 190 |
PLEURAL EFFUSION |
2 |
0.0000 |
| 191 |
EMOTIONAL DISORDER |
1 |
0.0000 |
| 192 |
PRODUCT DOSE OMISSION |
2 |
0.0000 |
| 193 |
ABDOMINAL PAIN |
7 |
0.0000 |
| 194 |
VIRAL INFECTION |
1 |
0.0000 |
| 195 |
CHEST DISCOMFORT |
3 |
0.0000 |
| 196 |
HAEMATURIA |
1 |
0.0000 |
| 197 |
AGITATION |
2 |
0.0000 |
| 198 |
DYSURIA |
1 |
0.0000 |
| 199 |
PRODUCT STORAGE ERROR |
2 |
0.0000 |
| 200 |
INTENTIONAL PRODUCT USE ISSUE |
2 |
0.0000 |
| 201 |
PULMONARY OEDEMA |
1 |
0.0000 |
| 202 |
INCORRECT DOSE ADMINISTERED |
5 |
0.0000 |
| 203 |
SKIN DISCOLOURATION |
1 |
0.0000 |
| 204 |
DECREASED APPETITE |
5 |
0.0000 |
| 205 |
RASH |
9 |
0.0000 |
| 206 |
LUNG DISORDER |
1 |
0.0000 |
| 207 |
FLUSHING |
2 |
0.0000 |
| 208 |
INFLAMMATION |
1 |
0.0000 |
| 209 |
HEADACHE |
12 |
0.0000 |
| 210 |
TREATMENT NONCOMPLIANCE |
1 |
0.0000 |
| 211 |
PRURITUS |
7 |
0.0000 |
| 212 |
HAEMATOCHEZIA |
1 |
0.0000 |
| 213 |
FALL |
6 |
0.0000 |
| 214 |
MEDICATION ERROR |
1 |
0.0000 |
| 215 |
WEIGHT DECREASED |
5 |
0.0000 |
| 216 |
ABDOMINAL DISCOMFORT |
3 |
0.0000 |
| 217 |
WEIGHT INCREASED |
4 |
0.0000 |
| 218 |
COUGH |
5 |
0.0000 |
| 219 |
HYPONATRAEMIA |
1 |
0.0000 |
| 220 |
MUSCULAR WEAKNESS |
2 |
0.0000 |
| 221 |
URINARY TRACT INFECTION |
3 |
0.0000 |
| 222 |
LETHARGY |
1 |
0.0000 |
| 223 |
CATARACT |
1 |
0.0000 |
| 224 |
NAUSEA |
13 |
0.0000 |
| 225 |
VERTIGO |
1 |
0.0000 |
| 226 |
DISCOMFORT |
1 |
0.0000 |
| 227 |
CHEST PAIN |
3 |
0.0000 |
| 228 |
ASTHENIA |
6 |
0.0000 |
| 229 |
RHINORRHOEA |
1 |
0.0000 |
| 230 |
INFUSION RELATED REACTION |
1 |
0.0000 |
| 231 |
BLOOD PRESSURE DECREASED |
1 |
0.0000 |
| 232 |
HEPATIC ENZYME INCREASED |
1 |
0.0000 |
| 233 |
DIZZINESS |
7 |
0.0000 |
| 234 |
THERAPY INTERRUPTED |
1 |
0.0000 |
| 235 |
OVERDOSE |
3 |
0.0000 |
| 236 |
RESPIRATORY FAILURE |
1 |
0.0000 |
| 237 |
PAIN IN EXTREMITY |
4 |
0.0000 |
| 238 |
BRONCHITIS |
1 |
0.0000 |
| 239 |
EPISTAXIS |
1 |
0.0000 |
| 240 |
HOT FLUSH |
1 |
0.0000 |
| 241 |
HOSPITALISATION |
2 |
0.0000 |
| 242 |
PERIPHERAL SWELLING |
2 |
0.0000 |
| 243 |
CARDIAC FAILURE |
1 |
0.0000 |
| 244 |
CARDIAC ARREST |
1 |
0.0000 |
| 245 |
TREMOR |
2 |
0.0000 |
| 246 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
2 |
0.0000 |
| 247 |
NASOPHARYNGITIS |
2 |
0.0000 |
| 248 |
DIARRHOEA |
7 |
0.0000 |
| 249 |
HYPERSENSITIVITY |
2 |
0.0000 |
| 250 |
CARDIAC DISORDER |
1 |
0.0000 |
| 251 |
ANXIETY |
3 |
0.0000 |
| 252 |
DYSPHAGIA |
1 |
0.0000 |
| 253 |
NEUROPATHY PERIPHERAL |
1 |
0.0000 |
| 254 |
ANAEMIA |
2 |
0.0000 |
| 255 |
MIGRAINE |
1 |
0.0000 |
| 256 |
PAIN |
6 |
0.0000 |
| 257 |
ABDOMINAL PAIN UPPER |
2 |
0.0000 |
| 258 |
ABDOMINAL DISTENSION |
1 |
0.0000 |
| 259 |
FATIGUE |
7 |
0.0000 |
| 260 |
SEPSIS |
1 |
0.0000 |
| 261 |
SEIZURE |
1 |
0.0000 |
| 262 |
PALPITATIONS |
1 |
0.0000 |
| 263 |
JOINT SWELLING |
1 |
0.0000 |
| 264 |
RENAL FAILURE |
1 |
0.0000 |
| 265 |
DRY SKIN |
1 |
0.0000 |
| 266 |
VISION BLURRED |
1 |
0.0000 |
| 267 |
DYSPNOEA |
4 |
0.0000 |
| 268 |
INFECTION |
1 |
0.0000 |
| 269 |
ACUTE KIDNEY INJURY |
1 |
0.0000 |
| 270 |
PARAESTHESIA |
1 |
0.0000 |
| 271 |
URTICARIA |
1 |
0.0000 |
| 272 |
MYALGIA |
1 |
0.0000 |
| 273 |
ALOPECIA |
1 |
0.0000 |
| 274 |
DEPRESSION |
1 |
0.0000 |
| 275 |
BACK PAIN |
1 |
0.0000 |
| 276 |
DEATH |
3 |
0.0000 |
| 277 |
CONDITION AGGRAVATED |
1 |
0.0000 |
| 278 |
OFF LABEL USE |
1 |
0.0000 |
| 279 |
DRUG INEFFECTIVE |
1 |
0.0000 |